Article Sidebar
Published:
Feb 18, 2023Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Pinellia polysaccharide activates PI3K/AKT signaling pathway and regulates the expression of airway smooth muscle related apoptosis molecules in airway remodeling in rats with cough variant asthma
Abstract
Purpose: To investigate the effect of Pinellia polysaccharide on airway remodeling in cough-variant asthmatic rats, and the involvement of PI3K/AKT signal route in the process.
Methods: Seventy-five Sprague-Dawley (SD) rats were assigned to 5 groups: blank control, model, low-dose Pinellia polysaccharide (100 mg/kg), medium-dose Pinellia polysaccharide (200 mg/kg) and high-dose Pinellia polysaccharide (400 mg/kg) groups, each with 15 rats. Immunoblot assay was employed to measure relative protein concentrations of phosphorylated protein kinase B (p-AKT), phosphorylated phosphoinositide-3-kinase (p-PI3K), MMP-9, B lymphocytes expression of cell tumor-2, B-lymphoma-2 gene-related promoter (Bad), Fas, and Caspase-3.
Results: The levels of Wat, Wam, Wai, p-AKT, p-PI3K, MMP-9 and bcl-2 in model group were significantly higher than those in blank control group (p < 0.05). However, these factors were significantly up-regulated, relative to blank control levels, but lower than those in the model group (p < 0.05). The levels of Bad, Fas and Caspase3 in the model group were significantly lower than the corresponding levels in the blank control group (p < 0.05). Moreover, levels of Bad, Fas and Caspase3 differed significantly amongst rats given the 3 doses of Pinellia polysaccharide (p < 0.05).
Conclusion: Pinellia polysaccharide mitigates cough-variant asthma in rats through stimulation of PI3K/AKT signal route, regulation of expressions of airway smooth muscle-related apoptotic molecules (Bad, Fas and Caspase-3), and slowing down airway remodeling and airway inflammation. Thus, this polysaccharide is a potential agent for the management of cough variant asthma.
